Supplementary Data from CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Abstract

Supplemental Table 1. Phenotypic characterization of patient-derived CSPG4-CAR.CIK and unmodified NTD.CIK